Skip to content

Earnings call

Narayana Hrudayalaya Q2 FY27 earnings call

By . Assembled by software from the company's transcript. Not reviewed by a person.

Transcript filed .

The transcript names the quarter but not the year. The year is worked out from the date it was filed.

The company said a 5 to 7-year time horizon is a good way to evaluate the U.K. business because it has just entered and has a journey to achieve in that business. The company will share guidance on bed additions 1 quarter in advance, when its facilities are ready to be commissioned. Cayman Islands insurance losses were approximately $5.4 million 2 quarters ago, $3.7 million in the previous quarter and $1.1 million this quarter; the reduction from $3.7 million to $1.1 million was attributed to repricing, purging poor performing accounts and improving processes. For Narayana Hrudayalaya's U.K. business, NHS contracts are reset every March, with changes effective only from 1st April of the following year, as the financial year starts on April 1st.

The numbers management gave

Results

  • The company said the combined loss of the insurance and clinic businesses was around INR33 crores last quarter and INR22 crores this quarter.
    Show source
    The combined loss of the 2 businesses was around INR33 crores last quarter, and this quarter it is INR22 crores.
  • Cayman Islands insurance losses were approximately $5.4 million 2 quarters ago, $3.7 million in the previous quarter and $1.1 million this quarter; the reduction from $3.7 million to $1.1 million was attributed to repricing, purging poor performing accounts and improving processes.
    Show source
    Even for Cayman, if you look at the insurance losses, the number is down from $3.7 million to $1.1 million.
  • Group-level ROCE is between 15% to 16%, reflecting investment in Cayman and investment in U.K. and India entering the capex phase.
    Show source
    Sandhya Jayaraman: So at a group level, our ROCE is between 15% to 16%.
  • Inpatient footfalls grew 6% quarter-on-quarter and almost 4% year-on-year.
    Show source
    Our IP footfalls have actually grown 6% quarter- on-quarter and almost 4% year-on-year.
  • International patients contribute around 6% to 7% of hospital revenue, and the company said it does not specifically target them.
    Show source
    International patients contribute around 6% to 7% of hospital revenue, but it is not something we specifically target.
  • International patient growth is organic and comes mainly from Bangladesh, supported by the brand and loyalty built there over the last 2.5 decades and easier visa and travel conditions.
    Show source
    The growth is purely organic and comes mainly from Bangladesh, because of the brand and loyalty we have built there over the last 2.5 decades, supported by easier visa and travel conditions.
Show 13 more statements

Results

  • Traditionally calculated occupancy has been 60% to 65%, and it has not added capacity or increased occupancy in the past several quarters.
    Show source
    We have been hovering at 60% to 65% in the way it is traditionally calculated.
  • Health insurance business had a loss of around INR14 crores and its clinics had a loss of around INR8 crores, compared with INR19 crores and INR14 crores, respectively, last quarter.
    Show source
    Sandhya Jayaraman: I think INR 223 Million, roughly half-half but insurance is slightly higher Nishant Singh : Health insurance is around INR14 crores and clinics around INR8 crores.
  • Cayman Islands insurance losses of $1.1 million this quarter included a one-off effect from summer school holiday months, when people tend to defer elective care and travel with family.
    Show source
    But this -- the $1.1 million does have some one-off because it includes the summer school holiday months, when people tend to defer elective care, they'll be on holidays, travel with family, etcetera.
  • Revenues went up by 9% quarter-on-quarter, largely on a fixed clinical and nursing cost base, allowing these costs to come down by around 1.9% from the previous quarter through operating leverage.
    Show source
    That is why these costs have come down by around 1.9%.
  • The company said it had seen good growth in outpatient and inpatient volumes in the last few quarters compared with a couple of quarters ago.
    Show source
    All in all, we have done in the last few quarters, we've seen good growth in both outpatient and inpatient volumes compared with a couple of quarters ago.
  • The company said higher throughput through its facilities has driven revenue uplift, higher volumes processed and cost leverage flowing through into margins.
    Show source
    But you can see the leverage impact of higher throughput going through the facilities, both in terms of the revenue uplift that we have seen, the higher volumes that we are able to process, and the cost leverage we have earned, which flows through into margins.
  • U.K. business has made changes to its consumables and supply chain strategy, and the results are active in the business.
    Show source
    We've made a lot of changes in our consumables and supply chain strategy.
  • Percentage of U.K. business from private sources is increasing, with small steps already flowing in.
    Show source
    With the private sources, we are seeing already small steps flowing in and the percentage of our business from private sources is increasing, which is what we want to see.
  • Cayman Islands insurance losses are coming down rapidly, which is its stated intention.
    Show source
    But directionally, we are seeing our losses come down very rapidly, which is our stated intention.
  • After acquiring only the hospitals, Narayana Hrudayalaya had to novate its external vendor agreements and enter fresh agreements, and vendors had an opportunity to raise prices, creating diseconomies of scale and higher day-to-day costs after separation.
    Show source
    So we -- that was what we mean by separation costs where a lot of the day-to-day cost of the business once we separated out the company were higher for us.
  • The company said its U.K. private, or non-NHS, revenue is increasing, with small steps toward growing its non-NHS books of business; it did not disclose the exact percentage.
    Show source
    On the last part of your question, on private, that is non-NHS revenue, we are seeing an increase.
  • The company said quarter-on-quarter changes in Cayman ARPP, ARPOB or ALOS are not informative because of seasonal variation and the low-volume base; a single large patient discharge can distort them, so volumes are the trend to follow.
    Show source
    A single large patient discharge can distort these meaningfully, so the trend to follow would be volumes.
  • The company is seeing early results in its U.K. business. Replaced by a later filing.
    Show source
    We are seeing early results.

What it expects ahead

What management expects

  • The company said a 5 to 7-year time horizon is a good way to evaluate the U.K. business because it has just entered and has a journey to achieve in that business.
    Show source
    For the U.K. business, I think a 5 to 7-year time horizon is a good way of looking at the business because we have just entered and there is a journey that we have to achieve on that business.
  • The company foresees good inpatient and outpatient footfall growth in Q3 and Q4, supported by a strong base and good funnel created across all regions over the last 2 quarters.
    Show source
    And with the strong base and good funnel which have been created over the last 2 quarters across all the regions, we foresee good footfall growth both from inpatient side and outpatient side in Q3 and Q4.
  • The company thinks its U.K. digital platform is about 4 to 5 months away from receiving all certifications, after which it will start implementing Athma.
    Show source
    Page 12 of 19 Narayana Hrudayalaya Limited November 02, 2026 We think that's about 4 to 5 months away from getting all certifications, and then we'll start the implementation of Athma, which will be a significant change forward.
  • The company expects prices for Cayman Islands insurance contracts to be reset in January for a smaller cohort, with the big reset in July 2027.
    Show source
    The big reset will happen in July 2027.
  • The company hopes to see negligible Cayman Islands insurance losses before July 2027 and expects to have exited almost all unprofitable books from July onwards.
    Show source
    Hopefully, even before that, we'll see negligible losses, and from July onwards we will have exited almost all unprofitable books.
  • U.K. cost initiatives started flowing through this month or a few weeks ago or 1 or 2 months ago, and their annualized effect will flow in over time.
    Show source
    So the annualized effect will flow in as we go.
Show 22 more statements

What management expects

  • The company said that 3 million, 4 million additional revenue for the quarter compared with 1 or 2 quarters back would start bringing through the benefits of its recent changes; the effects will flow in over a few quarters.
    Show source
    So even if you go 1 or 2 quarters back, which is just 3 million, 4 million additional revenue for the quarter, we will start seeing these benefits flow in.
  • The company aims to reach a point where it is not burning cash in insurance and can deliver care to customers while financing it with support from the insurance arm.
    Show source
    We want to get to a point, where we are not burning cash in insurance, and we are able to deliver the care that we want to deliver to our customers, while taking care of the financing by -- supported by the insurance arm.
  • The company expects much stronger footfall growth from the Eastern region in Q3.
    Show source
    We expect much stronger footfall growth from the Eastern region in Q3.
  • The company expects volumes in the smaller units in the Karnataka cluster to eventually pick up in the coming quarters after rationalizing payer mix to maintain reasonable volumes and good realization.
    Show source
    In the smaller units in the Karnataka cluster, we have been rationalizing our payer mix, which we continue to strive Page 6 of 19 Narayana Hrudayalaya Limited November 02, 2026 on, to ensure we have reasonable volumes and good realization, which is again a journey, and we expect these volumes to eventually pick up in the coming quarters.
  • The company expects its understanding of customers' health to help it manage risk and evaluate the insurance portfolio better and bring synergies.
    Show source
    And this can, therefore, help us manage risk better and evaluate the portfolio better and bring on some of the synergies that Viren was referring to earlier.
  • The company says it is too soon to decide whether to become an insurance distribution entity; it expects to decide after the final guidelines come out.
    Show source
    Other parts of this, whether we should become an insurance distribution entity, etcetera, it's too soon to say.
  • The company thinks the insurance regulations will support its current strategy.
    Show source
    But based on what we are seeing at the moment, we think that the regulations will actually support our current strategy.
  • U.K. business has made progress on revenue-building blocks, but they have not yet translated into additional revenue; the company hopes that will change fairly soon.
    Show source
    But as you rightly identified, it's not yet translating into additional revenue into the business, but we hope that will change fairly soon.
  • U.K. business faces a learning curve in revenue because it is a new market, and acquiring private patients will take time.
    Show source
    There are some initial building block steps that we are working through, but it will take some time for us to get a better grip of how to acquire private patients and start that.
  • The company does not think it will take a year or two to get its U.K. business back to a decent level of revenue.
    Show source
    But I don't think it is going to take that long.
  • The company expects to have a better idea over the next few quarters of how long revenue recovery will take in the U.K. market.
    Show source
    But we'll have a much better idea over the next few quarters, and we will ourselves get a better sense about predicting the -- how long these things will take in this market.
  • Insurance business will initially be more group heavy, and the group share will moderate over time.
    Show source
    Initially, of course, it is going to be more group heavy and that will moderate out over a period of time.
  • The company said its size limits and anchors growth in Cayman, a small island, and that the best days of growth for Cayman are behind it.
    Show source
    Our size is a limiting factor and an anchor on our growth in that small island.
  • The company expects its overall cash conversion cycle not to be negatively affected by the U.K. business.
    Show source
    Our overall cash conversion cycle is not going to be negatively affected because of the U.K. business.
  • Some of Narayana Hrudayalaya's U.K. cost changes are already flowing through, but a slight quarter-on-quarter revenue decline means cost efforts are not yet flowing into earnings; the company expects the benefits to become more visible when revenue picks back up.
    Show source
    Page 16 of 19 Narayana Hrudayalaya Limited November 02, 2026 But because of the slight revenue decline that we're seeing quarter-on-quarter, we're not seeing our cost -- any cost efforts flowing into earnings yet.
  • The company said it does not guide on margins; Q2 is a higher-margin quarter and Q3 is slightly muted, so it advised following the healthcare trend rather than extrapolating the current quarter.
    Show source
    So you should go with the trend you've seen in Page 17 of 19 Narayana Hrudayalaya Limited November 02, 2026 health care rather than extrapolate the current quarter.
  • The company is focusing on growing its retail insurance business with sales to hospital customers and expects to remain focused on it. Replaced by a later filing.
    Show source
    As I mentioned earlier, we are focusing on growing our retail business with sales to hospital customers.
  • The company does not anticipate any significant changes to its insurance strategy at this point. Replaced by a later filing.
    Show source
    We don't, at this point, anticipate any significant changes to our strategy.
  • Goal for its U.K. business is to grow revenue from non-NHS sources. Replaced by a later filing.
    Show source
    Our goal really is to grow the non-NHS sources of revenue.
  • The company is not focusing on growth in Cayman Islands insurance until it brings losses down; progress is according to plan and better than planned. Replaced by a later filing.
    Show source
    We're not focusing on growth in insurance until we bring the losses down.
  • The company said it continues to see good growth from non-Cayman sources, that is international patients. Replaced by a later filing.
    Show source
    We continue to see good growth from non-Cayman sources, that is international patients.
  • The company said that continuing cost discipline while growing volumes and revenues will provide more benefits in the coming quarters. Replaced by a later filing.
    Show source
    We continue to work on costs and the disciplines around the cost while we keep growing the volumes and revenues, which will keep giving more and more benefits in the coming quarters.

What it is building and selling

Projects and capacity

  • The company will share guidance on bed additions 1 quarter in advance, when its facilities are ready to be commissioned.
    Show source
    As and when our facilities are ready to be commissioned, we will share that guidance 1 quarter in advance.
  • The company has set up a GCC for its U.K. business, which is growing quite well and provides another cost efficiency.
    Show source
    As Sandhya and the colleagues pointed out, we've set up our GCC that's growing quite well.
  • The company is making progress on regulatory certification and compliance for its U.K. digital platform. Replaced by a later filing.
    Show source
    And we are making good progress with getting our digital platform regulatory certified with the regulators and compliant.

Demand and pricing

  • The company says NHS contracting has seasonality and is affected by political compulsions, patient waiting lists and annual resets of activity plans, making it more predictable.
    Show source
    There are both political compulsions to contracting as well as the practical realities of patient waiting list and the activity plans being reset once a year.
  • U.K. business remains heavily dependent on NHS, so small gains in private revenue can be outweighed by even a tiny deterioration in NHS revenue because NHS is such a large part of the revenue pool.
    Show source
    But as long as we're so heavily dependent on NHS, any small move forward in private will be completely undone and more by even a tiny deterioration in NHS because it's such a big constituent of the revenue pool.
  • NHS contracting slowed down for all providers in the market. Replaced by a later filing.
    Show source
    Separately, the NHS did slow down contracting for all providers in the market.
Show 6 more statements

Segments

  • For Narayana Hrudayalaya's U.K. business, NHS contracts are reset every March, with changes effective only from 1st April of the following year, as the financial year starts on April 1st.
    Show source
    The financial year starts on April 1st, so contracts get reset every March and any change is effective only from 1st April of the following year.
  • The company was the first hospital group to directly promote a health insurer.
    Show source
    We are the first hospital group to directly promote a health insurer.
  • The company considers hospitals a good channel for offering health insurance to customers, helping simplify the process and reduce cost.
    Show source
    So we agree that, for example, hospitals are a good channel to offer health insurance to customers, which is one of the distribution channels to approach to make the process simpler for the customer, reduce cost.
  • The company sells insurance to employers and employee groups; on a retail basis it sells largely, though not exclusively, to people who have a relationship with NH.
    Show source
    On a retail basis, we sell largely, though not exclusively, to people who have a relationship with NH.
  • U.K. business has three major revenue channels: NHS, private insurance and self-pay.
    Show source
    As far as revenue is concerned, there are 3 major channels: NHS, private insurance and self- pay, NHS is a once-a-year contracting relationship.
  • The company says hospitals have a greater understanding of customers' health over their lifetime because health insurance policies are lifelong. Replaced by a later filing.
    Show source
    And as a hospital, we also have a greater understanding of the customers' health, not just at time of sale, but over their lifetime because these are lifelong policies, and that's important.

Everything else said on the call

What management stressed

  • The company is building a large integrated health care system across at least 2 or 3 geographies to reduce exposure to any one country's currency depreciation or other macroeconomic risks and to serve different patient profiles and apply cross-country learnings.
    Show source
    So the thing we're trying to build is a very large integrated health care system across at least 2 or 3 geographies so that we're not exposed to any one country's, let's say, vagaries of whether it is currency depreciation or any sort of macroeconomic risk or be able to cater to different patient profiles across countries and leverage cross-country learnings from one country and then apply it to another.
  • The company said it cannot quantify the separation-related costs prior to the acquisition, but now knows what those costs are and is actively working to mitigate them.
    Show source
    Now there is no way to quantify this prior to the acquisition, but we do know what those costs are now, and we are working actively to mitigate that.
  • The company said it is comfortable with its execution pace on cost synergies but has work to do on revenue. Replaced by a later filing.
    Show source
    We're comfortable with our execution pace on the cost synergies.

Group structure

  • The company said it acquired only the hospitals from a company that was a division of a larger group running 3 business divisions.
    Show source
    We only acquired the hospitals.
  • The company is merging the clinic business into the hospital business, and the clinic model will be included in hospital numbers reported going forward; the company said it will be useful to look only at the insurance number going forward.
    Show source
    We are merging the clinic business into the hospital business, so going forward it will be useful to only look at the insurance number.

What the company said on its earnings call, taken from its own transcript. Not advice.

Questions and answers

  1. Question

    Prithvi Raj: This is from Unifi Capital. Firstly, on the India business margins. This quarter, the margins are around 25% and it's now almost on par with the best amongst the large players. However, the ARPOB is still at INR55,000 only compared to INR70,000 plus for others. Is there further scope for margin improvement as structurally ARPOBs improve or you think margins can be at this level for quite some time and then you will focus on revenue?

    Answer, r venkatesh

    R. Venkatesh: I'll take this. Prithvi Raj, Q2 is generally a strong quarter, as we have seen across financial years. And in this particular quarter, we've seen good growth both from the volume and price mix. So on IP volumes, we've seen 4% increase year-on-year. OP footfall, we've seen around 12.5% growth. ARPOB, as you said, has increased from INR17.5 million to INR19.5 million (annualised) year-on-year, as we focus more on high-end procedures and greater use of robotics. What we have seen is that moderate price increases and balanced pricing have driven strong growth in both IP and OP volumes this year.

    Answer, r venkatesh

    We will continue with the same strategy to ensure we have a balanced growth both in terms of volumes and realizations in the coming quarters as well. And on the margin side, yes, it has gone up to more than 26%, which is now among the best in the industry, even though our ARPOB remains well below peers. Along with better realizations, we've also had the benefit of operating leverage on the costs where our doctors and nursing costs have come down by 1.9% QoQ, which has added to the margin. And our focus will remain on seeing how we can sustain these margins at current levels.

  2. Question

    Prithvi Raj: So is there a further potential for margin improvement because your ARPOB will anyway structurally go up given the gap between competitors. So can we look at around 200 basis points of higher margins as a peak level? Page 2 of 19 Narayana Hrudayalaya Limited November 02, 2026 R. Venkatesh: So that is what I was trying to say… Viren Shetty: I'll jump in here Venkatesh.

    Answer, viren shetty

    Viren Shetty: Just to clarify, we don't target any specific margins. The margins you see, which are best-in- class despite an ARPOB that is significantly lower than peers, are a reflection of the huge amount of effort we've put in over the past 10 years in digitization, process improvement, supply chain and addressing every single driver of unnecessary cost in the company. Our mission has always been to cater to people who cannot afford treatment in most of the other private hospitals and to price our surgeries and procedures extremely affordably. The margin is a reflection of what we do once we end up paying for the very high cost of services balanced out against all the efficiencies we're able to bring in. So margin expansion isn't the thing that we target. What we're looking for is accessing the largest pool of patients in all the cities that we operate in. Volume growth is what we want to pursue.

  3. Question

    Prithvi Raj: And on the recent regulatory news on oncology price cap, etcetera, what exactly you're hearing from the government? And if any price cap that will get implemented, how will it impact Narayana?

    Answer, sandhya jayaraman

    Sandhya Jayaraman: Oncology is about 15% of India hospital revenue, and the drugs that have come under the cap are only a part of it. I think the caps will go live from 9th of November, and we'll have a better idea at that point in time. The only thing we want to call out is that we are not a very margin-focused company and a lot of our focus is on how efficiently we can run a high-volume standardized protocol, cost discipline driven care. So we will support anything that enables transparent and affordable pricing. There may be some ups and downs as this is implemented, which we will work through as we understand it better.

  4. Question

    Prithvi Raj: From our point of view, this journey towards clinics and insurance started 2.5, 3 years back. And back then, there were some committed investments that management has mentioned. And there were some time lines also mentioned. However, this journey is taking too long. And with every quarter or with every year, the losses are actually increasing. But at least at the management level, do you have any numbers saying you will try till you make certain losses and then you will end up giving up on insurance or you want to just keep pursuing at any cost? So how should we look at it?

    Answer, viren shetty

    We will spend in moderate amounts to keep our customers very happy to make sure that the claims don't go above and beyond what we had estimated for and to cut the cost in insurance distribution, which is currently a very high priority for the IRDAI Chairman, so that we can break even at a much smaller book than the peer set. Nishant Singh: Prithvi, just to correct, the numbers have not worsened. The combined loss of the 2 businesses was around INR33 crores last quarter, and this quarter it is INR22 crores. So the losses have come down actually. Even for Cayman, if you look at the insurance losses, the number is down from $3.7 million to $1.1 million. So actually, the trend is lower.

  5. Question

    Sajal Kapoor: No, that's helpful. And second is for maybe you, Sandhya, it's related to the ROCE regarding the U.K. and the insurance. So as we know both the U.K. and insurance businesses are at different stages of development. Over what time horizon should investors evaluate the ROCE of these ventures? And what milestones should we track along the way to distinguish a temporary investment phase from a structurally attractive return profile? Page 5 of 19 Narayana Hrudayalaya Limited November 02, 2026 Sandhya Jayaraman: Sure.

    Answer, sandhya jayaraman

    For the U.K. business, I think a 5 to 7-year time horizon is a good way of looking at the business because we have just entered and there is a journey that we have to achieve on that business. As far as the insurance business is concerned, we are not running a stand-alone health insurance company. It's part of the continuum of care. It is a way of financing health care for us. A stand-alone ROCE for insurance is not how we would measure ourselves internally. We want to get to a point, where we are not burning cash in insurance, and we are able to deliver the care that we want to deliver to our customers, while taking care of the financing by -- supported by the insurance arm. So that's really where we have to get to.

  6. Question

    Sajal Kapoor: Yes. No, absolutely, Sandhya. And just to clarify, I wasn't looking for segmental reporting of ROCE anyway at a consol level. At a group level, currently, the ROCE is not giving us a true reflection. So yes, I completely agree with the strategy around insurance and what you suggest. At some point in future, we should get a higher level of ROCE at an aggregate group level. That's precisely the question.

    Answer, sandhya jayaraman

    Sandhya Jayaraman: So at a group level, our ROCE is between 15% to 16%. That's because we've come off a huge investment in Cayman as well as the investment we've made in U.K. and India entering the capex phase. But the dilution, which is coming purely because of U.K. is about 4% to 5% that we will want to bridge over the next 5 years or so. As India also comes off the capex cycle, I think that's when the full effect of the -- all the measures will show on the ROCE.

  7. Question

    Shruti Mimani: Thanks for letting me ask the question. I'm from Clearstone Family Office. Just wanted to check on India, we have seen growth in revenues as well as margins have been better on the back of cost efficiencies and payer and case mix. But just wanted to check on the IP footfall, which has been around like 60,000 for a few quarters. So just what's happening there? And how do we see that going forward or how that impacts the drivers overall?

    Answer, r venkatesh

    R. Venkatesh: Yes. If you look at the numbers, the primary drivers in our Bangalore cluster and Calcutta cluster have done reasonably well in terms of footfall, which generate the major part of our revenues. And when it comes to Bangalore clusters, we're growing steadily quarter-on-quarter. In the Eastern cluster, there was a transition issue in porting certain categories of government scheme patients in Bengal, which should settle in the coming quarter, after which IP footfalls will gradually pick up. We expect much stronger footfall growth from the Eastern region in Q3. In the smaller units in the Karnataka cluster, we have been rationalizing our payer mix, which we continue to strive Page 6 of 19 Narayana Hrudayalaya Limited November 02, 2026 on, to ensure we have reasonable volumes and good realization, which is again a journey, and we expect these volumes to eventually pick up in the coming quarters. All in all, we have done in the last few quarters, we've seen good growth in both outpatient and inpatient volumes compared with a couple of quarters ago.

    Answer, r venkatesh

    And with the strong base and good funnel which have been created over the last 2 quarters across all the regions, we foresee good footfall growth both from inpatient side and outpatient side in Q3 and Q4.

  8. Question

    Shruti Mimani: Right. And just… Sandhya Jayaraman: And small data point, Shruti, I wanted to add.

    Answer, sandhya jayaraman

    Our IP footfalls have actually grown 6% quarter- on-quarter and almost 4% year-on-year. So we have been seeing IP growth on a continued basis between quarter. That's just for -- from a clarity point of view, though Venkatesh answered it in detail.

  9. Question

    Shruti Mimani: Yes, correct. And just on international patients, I've seen this quarter, we called out that there was increase in the payer mix also because of that. So what happened there? I just wanted to understand how are we thinking about international in the mix in India?

    Answer, r venkatesh

    R. Venkatesh: Yes. See, this is not an area we are specifically targeting. The growth is purely organic and comes mainly from Bangladesh, because of the brand and loyalty we have built there over the last 2.5 decades, supported by easier visa and travel conditions. International patients contribute around 6% to 7% of hospital revenue, but it is not something we specifically target. And when it comes to the volume, it is subject to a lot of these macro issues, which can fluctuate quarter-on-quarter. So there is no single explanation for the increase, and it can fluctuate from quarter to quarter. But on the whole, our focus has been more on domestic, and we've done well in terms of footfall in domestic, while the international on an organic basis has complemented things.

  10. Question

    Aryan Jain: This is Aryan from Groww Mutual Fund. So I have a couple of bookkeeping questions. So sir, what would be our occupancy ballpark in the India hospital business? And what would be the optimum level we can take it to from here?

    Answer, sandhya jayaraman

    Sandhya Jayaraman: Aryan, occupancy is not a metric we focus on. Typically, it's 60% to 65%, but we follow the throughput model because occupancy usually is calculated on midnight beds. And when you're doing more and more efficient turnaround on care, that gets distorted if you only look at occupancy. Page 7 of 19 Narayana Hrudayalaya Limited November 02, 2026 One good way to look at our numbers is that we haven't added any capacity and our occupancy has also not increased in the past several quarters. We have been hovering at 60% to 65% in the way it is traditionally calculated. But you can see the leverage impact of higher throughput going through the facilities, both in terms of the revenue uplift that we have seen, the higher volumes that we are able to process, and the cost leverage we have earned, which flows through into margins. It's coming through because we focus on throughput and not on occupancy.

Show 19 more questions
  1. Question

    Aryan Jain: Okay. Understood. And my second question would be -- would you be able to break down the INR 250 million loss of the insurance and clinic business?

    Answer, sandhya jayaraman

    Sandhya Jayaraman: I think INR 223 Million, roughly half-half but insurance is slightly higher Nishant Singh : Health insurance is around INR14 crores and clinics around INR8 crores. Last quarter, insurance was INR19 crores, which has now come down to INR14 crores, and clinics from INR14 crores to INR8 crores.

  2. Question

    Aryan Jain: Okay. And just one last one… Moderator: Aryan, I request you to rejoin the queue, please.

    Answer, sandhya jayaraman

    Sandhya Jayaraman: Just one follow-up, Aryan. We are merging the clinic business into the hospital business, so going forward it will be useful to only look at the insurance number. The clinic model is proven successful and merged into the numbers we'll report out for the hospital going forward. For the past several quarters, we have given both the numbers. So I think you will have a view of the trajectory already.

  3. Question

    Japreet Singh: And sir, my second question is with the U.K. acquisition entry and the forays in integrated care insurance and expansion coming in India, what is Narayana trying to become going forward?

    Answer, viren shetty

    Viren Shetty: I think one way to think about it is that we've developed a set of capabilities in India with running highly efficient hospitals. And there is a natural rate of growth that we've experienced within our existing network. We are adding more beds. We are adding more facilities in the hospitals over here. But our ambition is a lot more than that. And we saw in the U.K. and in the Caribbean an opportunity to expand our skill set and capabilities into a market where for the same amount of work, the realization is much, much larger than what is available in India. So the thing we're trying to build is a very large integrated health care system across at least 2 or 3 geographies so that we're not exposed to any one country's, let's say, vagaries of whether it is currency depreciation or any sort of macroeconomic risk or be able to cater to different patient profiles across countries and leverage cross-country learnings from one country and then apply it to another.

  4. Question

    Damayanti Kerai: This is Damayanti from HSBC Securities and Capital Markets Limited. My first question is to Sandhya. So we have been discussing you are setting up GCCs to manage the international business. So any impact we should broadly assume due to the currency volatility, say, INR against USD or GBP in your reported consol numbers? Page 10 of 19 Narayana Hrudayalaya Limited November 02, 2026 Sandhya Jayaraman: It is not linked to the GCC per se, because it's still a small number in the overall scheme of things of the company.

    Answer, sandhya jayaraman

    But you could see that when you look at our consol numbers in the OCI, you can see that there is a significant positive movement in the OCI coming in because of currency conversion. So there is some benefit of the currency because of all the work that we are doing from India for the international markets. But I don't think you'll need to factor something specific on that in the way of forecasting our business numbers.

  5. Question

    Damayanti Kerai: Sure. My second question is on India insurance business. So as we have been discussing, it's still in build-out phase. However, I just wanted to understand the team's thought process after recent regulatory development in the insurance sector, like after the announcement by the IRDAI, was there any change in the way you want to progress in your journey for the insurance compared to like when it started some time back?

    Answer, ravi vishwanath

    Ravi Vishwanath: Sure. So the headline Damayanti, as Viren just said, there is no real change at the moment. But overall, we do welcome the IRDAI regulations. I think any move that adds value for the customer is welcome for us. We are the first hospital group to directly promote a health insurer. So we agree that, for example, hospitals are a good channel to offer health insurance to customers, which is one of the distribution channels to approach to make the process simpler for the customer, reduce cost. And as a hospital, we also have a greater understanding of the customers' health, not just at time of sale, but over their lifetime because these are lifelong policies, and that's important.

    Answer, ravi vishwanath

    And this can, therefore, help us manage risk better and evaluate the portfolio better and bring on some of the synergies that Viren was referring to earlier. As I mentioned earlier, we are focusing on growing our retail business with sales to hospital customers. We expect to remain focused on the same. Other parts of this, whether we should become an insurance distribution entity, etcetera, it's too soon to say. The final guidelines are going to come out at some point. And once they come out, I think we'll take a call on it. But based on what we are seeing at the moment, we think that the regulations will actually support our current strategy.

    Answer, ravi vishwanath

    And so -- and we welcome it in general. We don't, at this point, anticipate any significant changes to our strategy. Page 11 of 19 Narayana Hrudayalaya Limited November 02, 2026 Damayanti Kerai: Sure.

  6. Question

    So Ravi, right now, all the insurance schemes are sold inside the hospitals only, right, hospitals and clinics to the patients who are coming in.

    Answer, ravi vishwanath

    Ravi Vishwanath: We sell to employers and employee groups. On a retail basis, we sell largely, though not exclusively, to people who have a relationship with NH. And that -- hopefully that will continue.

  7. Question

    Prithvi Raj: This is from Unifi Capital. I have 2 questions on international business. First is on U.K. Anesh, is it fair to assume that your top most priority for U.K. is to increase revenue as well as margins? What are the challenges that you have faced after you acquired this company, which happened a year back? And could you also elaborate the actions that you have taken, especially on the revenue front? I mean in the past, you have spoken a lot on the cost front, but especially on the revenue front, what are the initiatives that you have taken? And why is it not translating.

    Answer, anesh shetty

    Anesh Shetty: Sure. So Prithvi, you are right. Our initial and topmost priority is to improve earnings, which will come from a combination of both reducing our costs and growing revenue, as our earnings are disproportionately low compared with local peers, from a very low base. We have spoken - - as you said, we have spoken about what we're doing on the cost side. As far as revenue is concerned, there are 3 major channels: NHS, private insurance and self- pay, NHS is a once-a-year contracting relationship. The financial year starts on April 1st, so contracts get reset every March and any change is effective only from 1st April of the following year. Our goal really is to grow the non-NHS sources of revenue.

    Answer, anesh shetty

    But as you rightly identified, it's not yet translating into additional revenue into the business, but we hope that will change fairly soon. On the cost side, we have seen good changes. We've made a lot of changes in our consumables and supply chain strategy. Those results are active in the business. As Sandhya and the colleagues pointed out, we've set up our GCC that's growing quite well. So that is another cost efficiency. And we are making good progress with getting our digital platform regulatory certified with the regulators and compliant.

    Answer, anesh shetty

    Page 12 of 19 Narayana Hrudayalaya Limited November 02, 2026 We think that's about 4 to 5 months away from getting all certifications, and then we'll start the implementation of Athma, which will be a significant change forward. So again, on the cost side, I think things are on track. On the revenue side, there is a learning curve. It is a new market for us. There are some initial building block steps that we are working through, but it will take some time for us to get a better grip of how to acquire private patients and start that. We are seeing early results. Separately, the NHS did slow down contracting for all providers in the market.

  8. Question

    Prithvi Raj: Just a quick follow-up. If I ask for some time period, will it take a year or 2 years for you to at least get back to a decent level of revenue pool?

    Answer, anesh shetty

    Anesh Shetty: It depends what decent is, Prithvi. But I don't think it is going to take that long. See, the NHS, like I said, there is seasonality to it. There are both political compulsions to contracting as well as the practical realities of patient waiting list and the activity plans being reset once a year. So I think that is a little more predictable. With the private sources, we are seeing already small steps flowing in and the percentage of our business from private sources is increasing, which is what we want to see. But as long as we're so heavily dependent on NHS, any small move forward in private will be completely undone and more by even a tiny deterioration in NHS because it's such a big constituent of the revenue pool.

    Answer, anesh shetty

    But we'll have a much better idea over the next few quarters, and we will ourselves get a better sense about predicting the -- how long these things will take in this market.

  9. Question

    Prithvi Raj: Just one final question from my side on your Cayman Islands business. Obviously, hospitals continues to do exceptionally well. On the insurance piece, this quarter, there has been a significant reduction in the losses. And as per the last con call, I think in the month of Jan, there will be further reset of the insurance contracts. Once that happens, starting from Q4, should we expect a further significant reduction in the insurance losses? And shall we look at H2 FY28 for the breakeven?

    Answer, anesh shetty

    Anesh Shetty: Sure. If you look at the quarterly trend of insurance losses, approximately, it was $5.4 million 2 quarters ago, $3.7 million in the previous quarter and $1.1 million this quarter. The reduction from $3.7 million to $1.1 million is a huge one. Obviously, we are seeing significant reductions in the insurance losses as we are repricing and purging poor performing accounts, improving processes, etcetera. But this -- the $1.1 million does have some one-off because it includes the summer school holiday months, when people tend to defer elective care, they'll be on holidays, travel with family, etcetera. So there is some one-off in that. But directionally, we are seeing our losses come down very rapidly, which is our stated intention.

    Answer, anesh shetty

    We said that's the direction we're taking. We're not focusing on growth in insurance until we bring the losses down. So it is going according to plan, actually better than planned. Page 13 of 19 Narayana Hrudayalaya Limited November 02, 2026 We're very happy with the trajectory there. You are right, in January prices will get reset, but that's for a smaller cohort. The big reset will happen in July 2027. Hopefully, even before that, we'll see negligible losses, and from July onwards we will have exited almost all unprofitable books.

  10. Question

    Devang Patel: This is Devang from Sameeksha Capital. My question was on the India insurance business. You earlier mentioned we were trying to build up our SME book. So my question was that generally, we understand corporate is the more competitive part of the insurance business. So what is our current mix of retail versus corporate? And what is the ideal target mix for this.

    Answer, ravi vishwanath

    I think these are the more important things that we look at as opposed to just a random mix of group versus retail. Initially, of course, it is going to be more group heavy and that will moderate out over a period of time.

  11. Question

    Shruti Mimani: Shruti, again from Clearstone. Just on Cayman Hospitals piece, I mean it's been excellent growth. Partly I wanted to understand how have we been able to do this to get to this scale? And naturally, second piece is that given it's a small island, limited population, where can this max out or is there a cap to the revenue growth over time at some point? Yes. Page 14 of 19 Narayana Hrudayalaya Limited November 02, 2026 Anesh Shetty: Sure.

    Answer, anesh shetty

    And the new hospital did add a few new service lines. It's now about 1.5 years since we started that. But we've always maintained the best days of growth for Cayman are behind it. Our size is a limiting factor and an anchor on our growth in that small island. We continue to see good growth from non-Cayman sources, that is international patients. But for the Cayman story, the best days of growth are behind. We now are focusing on securing the patient base we have being a more comprehensive provider for the patients' need and executing on the integrated care strategy, which will allow us to have a non-volatile sort of safe patient and locked-in patient relationship for many decades to come.

  12. Question

    Sajal Kapoor: This is Sajal again from Antifragile Thinking. Just one more for you, Sandhya, if I may, on cash flow and working capital this time. So we know that the U.K. business currently carries approximately INR1,700-odd crores of net debt, while the EBITDA margin has declined from, I think, 8.8% to closer to 7% sequentially. More broadly, how are operating cash flow and working capital evolving across the group at a consol level, particularly the receivables and the cash conversion. Page 15 of 19 Narayana Hrudayalaya Limited November 02, 2026 And I'll explain the context where I'm coming from. So historically, if you go back last 10 -- 10 years since the IPO, we have converted roughly

    Answer, sandhya jayaraman

    Typically, on a full-year basis, this normalizes: in some quarters collections are a little slow, but we catch up over the next few months. So that's what we are expecting. Our overall cash conversion cycle is not going to be negatively affected because of the U.K. business.

  13. Question

    Rajit Aggarwal: I'm Rajit from Nilgiri Advisors. Just a couple of questions on the U.K. business. If you can provide a few more details on the cost side that led to the decline in EBITDA margins, given that there is a comment also which says the margins reflect near-term separation-related costs. So what was the extent of this impact? And how long is this supposed -- may last? The second question is on the payer mix. When we started, it was around 7% of revenue. So is it still the same or is it a couple of -- or a few basis points above or lower than 7%?

    Answer, anesh shetty

    Anesh Shetty: Sure. So Rajit, to your first question, when we acquired the business, the company we acquired was a division of a larger group that ran 3 business divisions. We only acquired the hospitals. Therefore, all our external vendors, for example, Microsoft or any and every kind of vendor had to -- we had to novate agreements and have essentially fresh agreements with these people. And naturally, as you can expect, there are certain diseconomies of scale when we went from a larger group to a smaller company, and it was also an opportunity for them to raise prices. So we -- that was what we mean by separation costs where a lot of the day-to-day cost of the business once we separated out the company were higher for us. Now there is no way to quantify this prior to the acquisition, but we do know what those costs are now, and we are working actively to mitigate that.

    Answer, anesh shetty

    On the second part of your question, some of the cost changes we are making are already flowing through. Page 16 of 19 Narayana Hrudayalaya Limited November 02, 2026 But because of the slight revenue decline that we're seeing quarter-on-quarter, we're not seeing our cost -- any cost efforts flowing into earnings yet. But when the revenue picks back up, that's when we expect these things to start being more visible. And also on an annual basis, these are initiatives that have just started flowing through this month or a few weeks ago or 1 or 2 months ago. So the annualized effect will flow in as we go. We're comfortable with our execution pace on the cost synergies. We just need -- we have some homework to do and work to do on the revenue front.

    Answer, anesh shetty

    On the last part of your question, on private, that is non-NHS revenue, we are seeing an increase. We are not disclosing the exact percentage, but we are seeing small steps towards growing the non-NHS books of business.

  14. Question

    Rajit Aggarwal: Right. So just as a quick follow-up, would you be able to share some top line number where these costs or you start to see the EBITDA benefits? Would it be 67% or 70% or something like that?

    Answer, anesh shetty

    Anesh Shetty: At a very simple level, we are comparing it to where it was. So even if you go 1 or 2 quarters back, which is just 3 million, 4 million additional revenue for the quarter, we will start seeing these benefits flow in. But more significantly, once -- with time because these are changes we've made very recently. So the effect of them will flow in over a few quarters.

  15. Question

    Vinay Nadkarni: Vinay again from Hathway Investments. Just one question. The doctors and nurses cost has gone down to 26% this quarter. Is it just because of the Q2 effect? Or is this a structural change that we are looking at?

    Answer, r venkatesh

    R. Venkatesh: Yes. This is -- basically, it largely reflects our operating leverage. If you look at quarter-on- quarter, our revenues have gone up by 9%. And it has gone up mostly on a largely fixed clinical cost base and the nursing cost base. And that is the reason why because of this leverage, we are able to get these costs much lower than what it was in the previous quarter. That is why these costs have come down by around 1.9%. We continue to work on costs and the disciplines around the cost while we keep growing the volumes and revenues, which will keep giving more and more benefits in the coming quarters.

  16. Question

    Vinay Nadkarni: So going forward, should we factor in around 26%, 27% or should we not?

    Answer, sandhya jayaraman

    Sandhya Jayaraman: We do not guide on margins, but as you know, quarters are seasonal in health care. Q2 is a higher margin quarter. Q3 is slightly muted. So you should go with the trend you've seen in Page 17 of 19 Narayana Hrudayalaya Limited November 02, 2026 health care rather than extrapolate the current quarter. There are also headwinds and tailwinds that keep operating. So you should follow the trend of the industry when you're forecasting.

  17. Question

    Aryan Jain: I'm Aryan from Groww Mutual Fund. So my question was on Cayman. This quarter, our ARPP saw 13% growth. Just wanted to understand what drove this growth?

    Answer, anesh shetty

    Anesh Shetty: Yes. Aryan, in Cayman, as we have said before, quarter-on-quarter changes in ARPP, ARPOB or ALOS are not informative. Those are not the metrics to look at. There is a lot of seasonal variation. In relative terms, it is still a low volume base that we're talking about because it's a small island. A single large patient discharge can distort these meaningfully, so the trend to follow would be volumes. We disclose discharge and outpatient volumes, and revenue trends are visible over several quarters.

  18. Question

    Aryan Jain: Okay. Understood. Fair enough. And one last question. So how do we generally manage attrition in India in our India hospital business or doctor level? Dr Emmanuel Rupert: We don't see too much of attrition at the senior level.

    Answer, emmanuel rupert

    We hardly have much of attrition, but we do have a strong program of mentoring and a lot of people do come to us as primary associations at the doctor level. So -- and we have a very strong DNB program across most specialties, especially the tertiary and quaternary specialties. We have close to around 900 postgraduates in training across the entire network. And we do have a strong mentorship and people joining us and progressing through the one level to another level. So we do have that reasonably covered. There might be some odd challenges here and there in Tier 2 and Tier 3 cities, but it is generally not something that we worry too much about at the senior level. Nursing has this usual attrition at every level, but we are fairly stable.

    Answer, emmanuel rupert

    We do have nursing schools and colleges. We have more than 3,000 nursing students in training. They have a very strong training program within the existing hospital network. And also with the use of this technology and especially the NAMAH app and the Athma, their nonclinical workload has come down significantly. It's come down by more than 50%, 60%. That makes that burnout and other things far, far lower and they are much more amenable to having a clinical care. So we generally don't have too much of a problem as far as this level.

  19. Question

    Just had one question before you disable the chat. Just wanted to know, since you are adding almost 635 beds in FY '28, when would you be able to give us rough quarterly additions for the next year?

    Answer, sandhya jayaraman

    Sandhya Jayaraman: I'm not sure a quarterly view is the right measure for bed additions. As and when our facilities are ready to be commissioned, we will share that guidance 1 quarter in advance.

Questions about this call

When was the Narayana Hrudayalaya Q2 FY27 earnings call transcript filed?
Narayana Hrudayalaya filed the transcript with the exchange on 7 Nov 2026. This page is built from that transcript.
What does this page list?
64 statements from the transcript across 7 topics, 19 of them with a figure. Each statement is shown with the transcript sentence it came from.
Are the analysts' questions included?
Yes. 29 questions and management's answers are listed in the order they were asked, as the transcript prints them.
Who wrote this page?
DalalOS Data Desk. Assembled by software from the company's transcript. Not reviewed by a person. How it is made, and what it leaves out, is on the method page linked from the byline.
Research and analysis only, not investment advice. Every statement on this page is the company's own, taken from its transcript; DalalOS adds no view on it and is not a SEBI-registered investment adviser. Something wrong? Report an error.
Narayana Hrudayalaya Q2 FY27 concall: what the company said · DalalOS